A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder.

Author: LokkerbolJoran, MavranezouliIfigeneia

Paper Details 
Original Abstract of the Article :
Bipolar disorder (BD) is a chronic mood disorder that causes substantial psychological and financial burden. Various pharmacological treatments are effective in the management and prevention of acute episodes of BD. In an era of tighter healthcare budgets and a need for more efficient use of resourc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s40273-016-0473-1

データ提供:米国国立医学図書館(NLM)

Navigating the Economic Landscape of Bipolar Disorder Treatment

Bipolar disorder (BD) is a chronic mental health condition imposing substantial psychological and financial burdens on individuals and society. As healthcare budgets tighten, it becomes increasingly important to evaluate the cost-effectiveness of various treatment options for BD. This study provides a comprehensive review of economic evaluations that have been conducted on pharmacological interventions for BD.

The review analyzes a range of studies that have assessed the cost-effectiveness of pharmacological treatments for BD, considering factors such as efficacy, duration of treatment, and associated costs. The authors critically evaluate the methodologies employed in these studies and identify areas for improvement in future research.

Economic Evaluation: A Crucial Tool for Informed Decision-Making

Economic evaluations provide valuable insights into the financial implications of different treatment options for BD. This information is essential for healthcare decision-makers to optimize resource allocation and ensure access to cost-effective treatments for all patients with BD.

Making Informed Choices: A Shared Responsibility

The findings from this study emphasize the importance of carefully considering the economic implications of treatment decisions for BD. By understanding the cost-effectiveness of various treatment options, individuals, healthcare professionals, and policy makers can work together to ensure equitable access to high-quality, affordable care for patients with BD.

Dr. Camel's Conclusion

This review, like a compass guiding us through the vast desert of healthcare economics, sheds light on the financial realities of treating bipolar disorder. By analyzing the cost-effectiveness of various medications, we gain a deeper understanding of how to maximize resources and ensure access to quality care for all individuals with BD. The findings underscore the need for ongoing research and collaboration to develop and implement cost-effective interventions that effectively address the needs of this complex population.

Date :
  1. Date Completed 2017-10-30
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

28000158

DOI: Digital Object Identifier

10.1007/s40273-016-0473-1

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.